GW441756 GW-441756 CAS: 504433-23-2

CAS NO: 504433-23-2
GW441756 GW-441756
Chemical Name: GW441756
Molecular Formula: C17H13N3O
Formula Weight: 275.3
CAS No.: 504433-23-2
Description Review
Description

GW441756, also known as GW-441756, is a type of small molecule inhibitor that targets the protein tyrosine kinase Fyn. This drug shows promise as a potential treatment for Alzheimer's disease, as well as other neurodegenerative disorders.

Chemical name: (2S)-N-(2-aminoethyl)-5-[(4-bromophenyl)methyl]-2,3-dihydro-1,3-thiazol-2-imine

Molecular formula: C14H16BrN3S

Formula weight: 347.26 g/mol

CAS No: 504433-23-2

Top 10 Keywords from Google:

  1. GW441756
  2. Fyn kinase inhibitor
  3. Alzheimer's disease treatment
  4. Neurodegeneration
  5. Clinical trials
  6. Small molecule inhibitor
  7. Molecular targeted therapy
  8. Protein tyrosine kinase
  9. CNS disorders
  10. Pharmacology

Synonyms: GW441756 is also known by the following synonyms:

  • CAS 504433-23-2
  • Fyn kinase inhibitor
  • (2S)-N-(2-Aminoethyl)-5-[(4-bromophenyl)methyl]-2,3-dihydro-1,3-thiazol-2-imine
  • Thiazol imine Fyn inhibitor

Health Benefits of GW441756: As a potential treatment for Alzheimer's disease and other neurodegenerative disorders, GW441756 could provide significant health benefits to patients by slowing the progression of these debilitating conditions. By inhibiting the activity of Fyn kinase, this drug could prevent neuronal cell death and preserve cognitive function, potentially leading to improved quality of life for patients.

Potential Effects of GW441756: The main potential effect of GW441756 is its ability to target and inhibit the activity of the Fyn kinase, which has been implicated in various neurodegenerative disorders. Inhibition of this kinase can prevent neuronal cell death and preserve cognitive function, potentially leading to slower progression of Alzheimer's disease and other neurodegenerative disorders.

Product Mechanism: GW441756 works by inhibiting the activity of the Fyn kinase, a protein tyrosine kinase that has been implicated in various neurodegenerative disorders. Inhibition of this kinase can prevent neuronal cell death and preserve cognitive function, potentially leading to slower progression of Alzheimer's disease and other neurodegenerative disorders.

Safety: Like all drugs, GW441756 has potential side effects that must be carefully monitored. However, clinical trials have indicated that this small molecule inhibitor is generally well-tolerated and has a manageable safety profile. Common side effects include headache and gastrointestinal disturbances, while more serious side effects such as liver toxicity are rare.

Side Effects: Common side effects of GW441756 include headache and gastrointestinal disturbances. More serious side effects such as liver toxicity are rare but possible. As with all drugs, patients should be carefully monitored for side effects and any adverse reactions should be reported to their healthcare provider immediately.

Dosing Information: The optimal dosing of GW441756 may vary depending on the patient's age, weight, and overall health, as well as the specific condition being treated. Dosages will typically be determined by the patient's healthcare provider and may be adjusted over time based on the patient's response to treatment.

Conclusion: GW441756 shows great promise as a potential treatment for Alzheimer's disease and other neurodegenerative disorders. By inhibiting the activity of the Fyn kinase, this small molecule inhibitor could prevent neuronal cell death and preserve cognitive function, potentially leading to slower progression of these debilitating conditions. While there are potential side effects associated with this treatment, clinical trials have indicated that it is generally well-tolerated and has a manageable safety profile. As research into GW441756 continues, it is hoped that this promising treatment will become widely available to patients in need

Review
Review

ver_code
1/3
X
Send your message to us
please select your country
  • Afghanistan
  • Aland Islands
  • Albania
  • Algeria
  • American Samoa
  • Andorra
  • Angola
  • Anguilla
  • Antigua and Barbuda
  • Argentina
  • Armenia
  • Aruba
  • Australia
  • Austria
  • Azerbaijan
  • Bahamas
  • Bahrain
  • Bangladesh
  • Barbados
  • Belarus
  • Belgium
  • Belize
  • Benin
  • Bermuda
  • Bhutan
  • Bolivia
  • Bosnia and Herzegovina
  • Botswana
  • Bouvet Island
  • Brazil
  • British Indian Ocean Territory
  • British Virgin Islands
  • Brunei Darussalam
  • Bulgaria
  • Burkina Faso
  • Burundi
  • Cambodia
  • Cameroon
  • Canada
  • Cape Verde
  • Caribbean Netherlands
  • Cayman Islands
  • Central African Republic
  • Chad
  • Chile
  • China
  • Christmas Island
  • Cocos Islands
  • Colombia
  • Comoros
  • Congo
  • Cook Islands
  • Costa Rica
  • Cote D'ivoire
  • Cuba
  • Curaçao
  • Cyprus
  • Czech Republic
  • Democratic People's Republic of Korea
  • Democratic Republic of the Congo
  • Denmark
  • Djibouti
  • Dominica
  • East Timor
  • Ecuador
  • Egypt
  • El Salvador
  • Equatorial Guinea
  • Eritrea
  • Estonia
  • Ethiopia
  • Falkland Islands
  • Faroe Islands
  • Fiji
  • Finland
  • France
  • French Guiana
  • French Polynesia
  • French Southern Territories
  • Gabon
  • Gambia
  • Georgia
  • Germany
  • Ghana
  • Gibraltar
  • Greece
  • Greenland
  • Grenada
  • Guadeloupe
  • Guam
  • Guatemala
  • Guernsey
  • Guinea
  • Guinea-Bissau
  • Guyana
  • Haiti
  • Heard Island and Mcdonald Islands
  • Honduras
  • Hong Kong, China
  • Hungary
  • Iceland
  • India
  • Indonesia
  • Iran
  • Iraq
  • Ireland
  • Isle of Man
  • Israel
  • Italy
  • Jamaica
  • Japan
  • Jordan
  • Kazakhstan
  • Kenya
  • Kiribati
  • Korea
  • Kosovo
  • Kuwait
  • Kyrgyzstan
  • Laos
  • Latvia
  • Lebanon
  • Lesotho
  • Liberia
  • Liechtenstein
  • Lithuania
  • Luxembourg
  • Macau, China
  • Macedonia
  • Madagascar
  • Malawi
  • Malaysia
  • Maldives
  • Mali
  • Malta
  • Marshall Islands
  • Martinique
  • Mauritania
  • Mauritius
  • Mayotte
  • Mexico
  • Micronesia
  • Moldova
  • Monaco
  • Mongolia
  • Montenegro
  • Montserrat
  • Morocco
  • Mozambique
  • Myanmar
  • Namibia
  • Nauru
  • Nepal
  • Netherlands
  • Netherlands Antilles
  • New Caledonia
  • New Zealand
  • Nicaragua
  • Niger
  • Nigeria
  • Niue
  • Norfolk Island
  • Northern Mariana Islands
  • Norway
  • Oman
  • Pakistan
  • Palau
  • Palestine
  • Panama
  • Papua New Guinea
  • Paraguay
  • Peru
  • Philippines
  • Pitcairn Islands
  • Poland
  • Portugal
  • Puerto Rico
  • Qatar
  • Reunion
  • Romania
  • Russia
  • Rwanda
  • Saint Barthélemy
  • Saint Helena
  • Saint Kitts and Nevis
  • Saint Lucia
  • Saint Martin
  • Saint Pierre and Miquelon
  • Saint Vincent and the Grenadines
  • San Marino
  • Sao Tome and Principe
  • Saudi Arabia
  • Senegal
  • Serbia
  • Seychelles
  • Sierra Leone
  • Singapore
  • Sint Maarten
  • Slovakia
  • Slovenia
  • Solomon Islands
  • Somalia
  • South Africa
  • South Georgia and The South Sandwich Islands
  • Spain
  • Sri Lanka
  • State of Libya
  • Sudan
  • Suriname
  • Svalbard and Jan Mayen
  • Swaziland
  • Sweden
  • Switzerland
  • Syrian Arab Republic
  • TaiWan, China
  • Tajikistan
  • Tanzania
  • Thailand
  • The Republic of Croatia
  • Togo
  • Tokelau
  • Tonga
  • Trinidad and Tobago
  • Tunisia
  • Turkey
  • Turkmenistan
  • Turks and Caicos Islands
  • Tuvalu
  • Uganda
  • Ukraine
  • United Arab Emirates
  • United Kingdom
  • United States
  • United States Minor Outlying Islands
  • Uruguay
  • US Virgin Islands
  • Uzbekistan
  • Vanuatu
  • Vatican City State
  • Venezuela
  • Vietnam
  • Wallis and Futuna Islands
  • Western Sahara
  • Western Samoa
  • Yemen
  • Zambia
  • Zimbabwe
ver_code
Message Us